Chemours Co. (CC) News
Filter CC News Items
CC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CC News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest CC News From Around the Web
Below are the latest news stories about CHEMOURS CO that investors may wish to consider to help them evaluate CC as an investment opportunity.
Chemours price target lowered to $21 from $22 at MizuhoMizuho lowered the firm’s price target on Chemours (CC) to $21 from $22 and keeps a Neutral rating on the shares. In conjunction with its 2025 outlook for the chemicals packaging space, the firm reduced estimates and price targets for several stocks. The March quarter “appears set to begin as weak” as the December quarter ended for most stocks, the analyst tells investors in a research note. Mizuho also updated its top picks, returning DuPont (DD) to top pick replacing Air Products (APD) with Li |
Is The Chemours Company (NYSE:CC) Trading At A 50% Discount?Key Insights Chemours' estimated fair value is US$37.18 based on 2 Stage Free Cash Flow to Equity Current share price... |
PCC Group to build $540M facility at Chemours’ Mississippi plant siteThe Germany-based company also signed a chlorine supply deal with the chemical titan. |
Chemours Appoints Google Executive Joseph Kava to its Board of DirectorsWILMINGTON, Del., January 07, 2025--Chemours Appoints Google Executive Joseph Kava to its Board of Directors |
Chemours Company (NYSE:CC): A Bullish Investment PerspectiveWe came across a long thesis on Chemours Company (NYSE:CC) on ValueInvestorsClub by Glory_Warriors. In this article we will summarize the bulls’ thesis on CC. The company’s shares were trading at $18.69 when this thesis was published, vs. closing price of $16.90 on Dec 31st. Chemours Company (NYSE:CC) is a global provider of chemicals, delivering […] |
Here’s Buckley Capital’s Updates on Chemours (CC)Buckley Capital Advisors, an investment management company, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here. Since the third quarter was not great, 2024 has not been a great year. The fund has not performed as well in relation to benchmarks, and this is the first time in […] |
The Chemours Company Announces Completion of Euro denominated Term Loan RepricingWILMINGTON, Del., December 13, 2024--The Chemours Company Announces Completion of Euro denominated Term Loan Repricing |
Chemours and PCC Group Enter Into Chlorine Supply AgreementCC takes a critical step further in its Pathway to Thrive operational excellence transformation by partnering with the PCC Group |
PCC Group Plans to Build Chlor-Alkali Facility at Chemours Titanium Dioxide Plant in DeLisle, MS Along the U.S. Gulf CoastWILMINGTON, Del., December 10, 2024--PCC Group plans to build and operate a state-of-the-art chlor-alkali facility at Chemours’ DeLisle, MS Titanium Dioxide Plant |
Why Is Albemarle (ALB) Up 1.2% Since Last Earnings Report?Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |